PARP inhibitor olaparib sensitizes cholangiocarcinoma cells to radiation.
- This topic has 0 replies, 1 voice, and was last updated 6 years, 4 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
PARP inhibitor olaparib sensitizes cholangiocarcinoma cells to radiation.
https://www.ncbi.nlm.nih.gov/pubmed/29479816
Viewing 1 post (of 1 total)
- The forum ‘Radiation Treatments & Options’ is closed to new topics and replies.